Sexual interaction is essential for the transformation of non-copulating rats into sexually active animals by the endocannabinoid anandamide.


Journal

Behavioural brain research
ISSN: 1872-7549
Titre abrégé: Behav Brain Res
Pays: Netherlands
ID NLM: 8004872

Informations de publication

Date de publication:
01 02 2019
Historique:
received: 17 08 2018
revised: 07 11 2018
accepted: 09 11 2018
pubmed: 16 11 2018
medline: 24 4 2019
entrez: 16 11 2018
Statut: ppublish

Résumé

The endocannabinoid anandamide (AEA) transforms half of the population of previously non-copulating (NC) rats into sexually active animals in a long-lasting manner. The aim of this work was to explore the nature of this transformation. We identified the dose range in which AEA induces mating behavior in previously NC rats, which evidenced a dose-based, biphasic profile for AEA to induce the transformation of NC rats. We demonstrate that the sexual interaction with a receptive female, involving at least an intromission, is essential for AEA to induce the transformation of NC rats. This AEA-induced conversion is centrally mediated and involves the activation of CB1 receptors. Results indicate that the sexual impairment of this population of NC rats relies on their incapacity to initiate sexual activity and that an unidentified brain inhibitory influence on sexual behavior expression is removed by AEA treatment, allowing previously NC rats to show copulatory behavior in a long-lasting manner. The inhibitory influence is not removed by AEA treatment when animals are not allowed to have sexual contact with the female immediately after AEA injection. The same result was found for the opioid receptor antagonist naloxone, the other treatment reported to induce copulation in rats classified as NC. These data suggest that sexual behavior expression could depend on two different neural mechanisms at two different moments: one involved in the display of the first copulatory response and another responsible for maintaining subsequent sexual behavior responding.

Identifiants

pubmed: 30439451
pii: S0166-4328(18)31188-4
doi: 10.1016/j.bbr.2018.11.015
pii:
doi:

Substances chimiques

Arachidonic Acids 0
Cannabinoid Receptor Modulators 0
Cnr1 protein, rat 0
Endocannabinoids 0
Piperidines 0
Polyunsaturated Alkamides 0
Pyrazoles 0
Receptor, Cannabinoid, CB1 0
Naloxone 36B82AMQ7N
AM 251 3I4FA44MAI
anandamide UR5G69TJKH

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

418-427

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Auteurs

Ana Canseco-Alba (A)

Departamento de Farmacobiología, CINVESTAV-Sede Sur, Calz. De los Tenorios 235, Col. Granjas Coapa, Ciudad de México 14330, Mexico. Electronic address: cansecoana@yahoo.com.mx.

Gabriela Rodríguez-Manzo (G)

Departamento de Farmacobiología, CINVESTAV-Sede Sur, Calz. De los Tenorios 235, Col. Granjas Coapa, Ciudad de México 14330, Mexico. Electronic address: grodrigu@cinvestav.mx.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH